These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29522653)

  • 21. Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.
    Temme L; Bechthold E; Schreiber JA; Gawaskar S; Schepmann D; Robaa D; Sippl W; Seebohm G; Wünsch B
    Eur J Med Chem; 2020 Mar; 190():112138. PubMed ID: 32070917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Pharmacological Evaluation of Enantiomerically Pure GluN2B Selective NMDA Receptor Antagonists.
    Börgel F; Szermerski M; Schreiber JA; Temme L; Strutz-Seebohm N; Lehmkuhl K; Schepmann D; Ametamey SM; Seebohm G; Schmidt TJ; Wünsch B
    ChemMedChem; 2018 Aug; 13(15):1580-1587. PubMed ID: 29806151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Biological Evaluation of Enantiomerically Pure (
    Korff M; Chaudhary A; Li Y; Zhou X; Zhao C; Rong J; Chen J; Xiao Z; Elghazawy NH; Sippl W; Davenport AT; Daunais JB; Wang L; Abate C; Ahmed H; Crowe R; Liang SH; Ametamey SM; Wünsch B; Haider A
    Res Sq; 2023 Jan; ():. PubMed ID: 36747738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common mechanism allows selective targeting of GluN2B subunit-containing
    Schreiber JA; Schepmann D; Frehland B; Thum S; Datunashvili M; Budde T; Hollmann M; Strutz-Seebohm N; Wünsch B; Seebohm G
    Commun Biol; 2019; 2():420. PubMed ID: 31754650
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of hydroxy moieties at the benzo[7]annulene ring system of GluN2B ligands: Design, synthesis and biological evaluation.
    Temme L; Börgel F; Schepmann D; Robaa D; Sippl W; Daniliuc C; Wünsch B
    Bioorg Med Chem; 2019 Dec; 27(23):115146. PubMed ID: 31648876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic properties of enantiomerically pure GluN2B selective NMDA receptor antagonists with 3-benzazepine scaffold.
    Börgel F; Galla F; Lehmkuhl K; Schepmann D; Ametamey SM; Wünsch B
    J Pharm Biomed Anal; 2019 Aug; 172():214-222. PubMed ID: 31060034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([
    Fu H; Tang W; Chen Z; Belov VV; Zhang G; Shao T; Zhang X; Yu Q; Rong J; Deng X; Han W; Myers SJ; Giffenig P; Wang L; Josephson L; Shao Y; Davenport AT; Daunais JB; Papisov M; Yuan H; Li Z; Traynelis SF; Liang SH
    ACS Chem Neurosci; 2019 May; 10(5):2263-2275. PubMed ID: 30698943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.
    Baumeister S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2020 Jan; 28(2):115245. PubMed ID: 31843460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (
    Cai L; Liow JS; Morse CL; Telu S; Davies R; Manly LS; Zoghbi SS; Chin FT; Innis RB; Pike VW
    EJNMMI Res; 2023 Apr; 13(1):28. PubMed ID: 37017827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil.
    Bechthold E; Schreiber JA; Ritter N; Schepmann D; Daniliuc C; Seebohm G; Wünsch B
    Eur J Med Chem; 2022 Jul; 237():114359. PubMed ID: 35468513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
    Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzimidazolone bioisosteres of potent GluN2B selective NMDA receptor antagonists.
    Lütnant I; Schepmann D; Wünsch B
    Eur J Med Chem; 2016 Jun; 116():136-146. PubMed ID: 27061977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists.
    Liu W; Jiang X; Zu Y; Yang Y; Liu Y; Sun X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2020 Aug; 200():112447. PubMed ID: 32450321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and characterization of
    Fuchigami T; Fujimoto N; Haradahira T; Nojiri Y; Okauchi T; Maeda J; Suhara T; Yamamoto F; Nakayama M; Maeda M; Mukai T
    J Labelled Comp Radiopharm; 2018 Dec; 61(14):1095-1105. PubMed ID: 30375667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist.
    Falck E; Begrow F; Verspohl E; Wünsch B
    J Pharm Biomed Anal; 2014 Jan; 88():96-105. PubMed ID: 24042122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenol-benzoxazolone bioisosteres of GluN2B-NMDA receptor antagonists: Unexpected rearrangement during reductive alkylation with phenylcyclohexanone.
    Markus A; Schreiber JA; Goerges G; Frehland B; Schepmann D; Daniliuc C; Fröhlich R; Seebohm G; Wünsch B
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200225. PubMed ID: 35908158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, GluN2B affinity and selectivity of benzo[7]annulen-7-amines.
    Gawaskar S; Schepmann D; Bonifazi A; Wünsch B
    Bioorg Med Chem; 2014 Dec; 22(23):6638-6646. PubMed ID: 25458498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.
    Zscherp R; Baumeister S; Schepmann D; Wünsch B
    Eur J Med Chem; 2018 Sep; 157():397-404. PubMed ID: 30103189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.